scispace - formally typeset
N

Naomoto Harada

Researcher at Merck & Co.

Publications -  11
Citations -  2384

Naomoto Harada is an academic researcher from Merck & Co.. The author has contributed to research in topics: Wnt signaling pathway & Beta-catenin. The author has an hindex of 9, co-authored 11 publications receiving 2255 citations.

Papers
More filters
Journal ArticleDOI

Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice.

TL;DR: Female Gpbar1 homozygous mice showed significant fat accumulation with body weight gain compared with that of the wild-type mice, indicating that Gp bar1 is a potential new player in energy homeostasis.
Journal ArticleDOI

Somatic activation of |[beta]|-catenin bypasses pre-TCR signaling and TCR selection in thymocyte development

TL;DR: It is reported here that conditional stabilization of β-catenin in immature thymocytes resulted in the generation of single positive T cells that lacked the αβ TCR and developed in the absence of pre-TCR signaling and TCR selection.
Journal ArticleDOI

Hepatocarcinogenesis in Mice with β-Catenin and Ha-Ras Gene Mutations

TL;DR: It is reported that hepatocellular carcinoma develops at the 100% incidence in mice with simultaneous mutations in the β-catenin and H-ras genes that are introduced by adenovirus-mediated Cre expression, and that these mice provide a convenient model to investigate early steps of hepatocarcinogenesis.